Complete regression of the irradiated tumor was observed in 42% of the mice treated with RT+CTLA4i+anti-CD40 (Fig. 10e); highly significant delayed progression of the abscopal tumor was also observed in this group, with two partial responses and one complete response reflecting in increased survival (Fig. 10f–i). The gene discussed is CD40; the disease is neoplasm.